Session # n/a

Hereditary Mutations in Colorectal Cancer: More than Meets the Diagnostic Eye.

Approximately 5-10% of colorectal cancer (CRC) has a hereditary basis. The clinical availability of hereditary multi-gene panel testing (MGPT) allows for CRC patients to be tested concurrently for common hereditary CRC syndromes such as Lynch syndrome, familial adenomatous polyposis (FAP), and MUTYH-associated polyposis (MAP), along with rare CRC syndromes such as juvenile polyposis syndrome (JPS). This study aimed to assess the prevalence of hereditary mutations among CRC patients undergoing MGPT and to describe the clinical histories and impact of the genetic test results for those with mutations detected.

• Authors: Alexandria Meyer; Emily Dalton; Rachel McFarland; Holly LaDuca
• Conference: ASCRS 2016
• Date: Saturday, Apr 30, 2016 3:00pm - 6:00pm